Medtronic SCORE Study - Study of Curette Use for Obtaining Restoration of Vertebral Body Anatomy in Balloon Kyphoplasty (MDTSCORE)
Vertebral Body Compression Fractures (VCFs)
About this trial
This is an interventional treatment trial for Vertebral Body Compression Fractures (VCFs)
Eligibility Criteria
Inclusion Criteria:
- Age >= 50 years
One painful VCF meeting all of the following criteria:
- Fracture due to diagnosed or suspected underlying primary or secondary osteoporosis
- VCF is between T5 and L5
- VCF shows hyperintense signal on STIR or T2 weighted MRI
- VCF has at least 15% height loss as visualized on plain radiograph
- Identified painful VCF has at least superior and one normal vertebrae within 2 levels inferior.
- Either the immediate superior OR the immediate inferior vertebral body (but not both) may have a chronic fracture that does not need treatment.
- Patient states availability for all study visits
- Patient is able to understand the risks and benefits of participating in the study and is willing to provide written informed consent
Exclusion Criteria:
- Patient is unable to undergo MRI
- Patient shows evidence of edema in vertebral bodies other than index level on MRI
- Patient is unable to stand for pre-operative and post-operative x-rays
- Patient body mass index (BMI) is greater than 35 kg/m2
- Patient is pregnant, or of child-bearing potential and not using contraception
- Vertebral body (VB) morphology or configuration is such that balloon kyphoplasty is not technically feasible or clinically appropriate for the index VCF
- Index fracture is result of high-energy trauma
- Suspected or proven cancer inside any VB
- Disabling back pain due to causes other than acute fracture
- Spine stabilization beyond balloon kyphoplasty required for index VCF
Pre-existing conditions contrary to balloon kyphoplasty, such as:
- Irreversible coagulopathy or bleeding disorder. Note that patients on Coumadin or other anticoagulants may participate. Investigators should follow routine practices for perioperative discontinuation and re-initiation of anticoagulants.
- Allergy to any device materials (e.g., bone cement) for balloon kyphoplasty. Note that in patients with allergy to iodine-based contrast, other marketed approved non-iodine contrast solutions may be used.
- Any evidence of VB or systemic infection
Sites / Locations
- Foundation for Orthopaedic Research and Education
- Atrium Medical Center
- Aurora Medical Group, Memorial Hospital of Burlington
- CHC - Les Cliniques Saint-Joseph
- St. Augustinus ziekenhuis
- Charité Campus Virchow-Klinikum Berlin
- Kliniken im Naturpark Altmühltal
- Klinikum Kempten
- Klinikum Leverkusen gGmbH
- Paracelcus-Klinik München
- Kliniken Dr. Erler
- Krankenhaus Barmherzige Bruder Regensburg
- Asklepios Orthopadische Klinik Lindenlohe
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Curette-First
IBT-First
All of patients in the study were treated with Balloon Kyphoplasty. During Balloon Kyphoplasty, two inflatable bone tamps (IBTs) are placed into the vertebral body bilaterally via a transpedicular or extrapedicular approach under fluoroscopic guidance. In this arm, curettage was performed prior to use of inflatable bone tamps.
All of patients in the study were treated with Balloon Kyphoplasty. During Balloon Kyphoplasty, two inflatable bone tamps (IBTs) are placed into the vertebral body bilaterally via a transpedicular or extrapedicular approach under fluoroscopic guidance. In this arm, inflatable bone tamps were used prior to curettage, then followed by a second inflation of the bone tamps.